We have located links that may give you full text access.
Journal Article
Research Support, Non-U.S. Gov't
Radiofrequency catheter ablation of ventricular tachycardia in children and young adults with congenital heart disease.
OBJECTIVES: The aim of this study was to expand data on outcomes for radiofrequency catheter ablation (RFCA) of ventricular tachycardia (VT) in young patients and to identify obstacles to success.
BACKGROUND: Ablation of VT is performed infrequently in young patients. Published experience has been limited to case reports and small descriptive series.
METHODS: A retrospective review of 97 consecutive VT ablation procedures involving 62 patients at a single institution from 1990 to 2003 was undertaken. All intention-to-treat procedures were analyzed.
RESULTS: Mean age was 13.9 +/- 9.4 years. Procedures were categorized according to VT mechanism as follows: idiopathic right ventricle (n = 37); idiopathic left ventricle (n = 24); congenital heart disease (n = 20); or other structural disease (n = 16). Acute success was achieved in 58 (60%) of 97 procedures. Of the 39 failures, 33 were aborted cases due to inability to induce sufficient ectopy for mapping in 12, high-risk location near the His bundle or coronary artery in 11, unstable VT in 7, and anatomic obstacles in 3. Recurrence rate after acutely successful RFCA was 34% (20/58 procedures) at a mean follow-up of 3.8 +/- 2.0 years. Ultimately, long-term success was achieved in 38 (61%) of 62 patients after a mean of 1.6 +/- 0.9 procedures, with the highest success rate (87%) for idiopathic left ventricular tachycardia.
CONCLUSIONS: When analyzed on a strict intention-to-treat basis, a long-term success rate of 61% is observed with ablation of VT in young patients. Inability to induce stable VT for precision mapping and certain high-risk VT locations can be significant obstacles to success.
BACKGROUND: Ablation of VT is performed infrequently in young patients. Published experience has been limited to case reports and small descriptive series.
METHODS: A retrospective review of 97 consecutive VT ablation procedures involving 62 patients at a single institution from 1990 to 2003 was undertaken. All intention-to-treat procedures were analyzed.
RESULTS: Mean age was 13.9 +/- 9.4 years. Procedures were categorized according to VT mechanism as follows: idiopathic right ventricle (n = 37); idiopathic left ventricle (n = 24); congenital heart disease (n = 20); or other structural disease (n = 16). Acute success was achieved in 58 (60%) of 97 procedures. Of the 39 failures, 33 were aborted cases due to inability to induce sufficient ectopy for mapping in 12, high-risk location near the His bundle or coronary artery in 11, unstable VT in 7, and anatomic obstacles in 3. Recurrence rate after acutely successful RFCA was 34% (20/58 procedures) at a mean follow-up of 3.8 +/- 2.0 years. Ultimately, long-term success was achieved in 38 (61%) of 62 patients after a mean of 1.6 +/- 0.9 procedures, with the highest success rate (87%) for idiopathic left ventricular tachycardia.
CONCLUSIONS: When analyzed on a strict intention-to-treat basis, a long-term success rate of 61% is observed with ablation of VT in young patients. Inability to induce stable VT for precision mapping and certain high-risk VT locations can be significant obstacles to success.
Full text links
Related Resources
Trending Papers
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities.Diabetologia 2024 April 17
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Eosinophilic Esophagitis: Clinical Pearls for Primary Care Providers and Gastroenterologists.Mayo Clinic Proceedings 2024 April
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app